R

R&G PharmaStudies Co Ltd
SZSE:301333

Watchlist Manager
R&G PharmaStudies Co Ltd
SZSE:301333
Watchlist
Price: 49.52 CNY -4.55% Market Closed
Market Cap: 4.8B CNY
Have any thoughts about
R&G PharmaStudies Co Ltd?
Write Note

Cash Flow Statement

Cash Flow Statement
R&G PharmaStudies Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Cash Taxes Paid
(45)
(44)
(44)
(46)
(41)
(42)
(50)
(57)
(59)
(76)
Change in Working Capital
(364)
(372)
(386)
(392)
(389)
(391)
(365)
(395)
(403)
(508)
Cash from Operating Activities
115
N/A
113
-1%
127
+12%
154
+21%
130
-15%
144
+10%
197
+37%
193
-2%
198
+3%
236
+19%
Investing Cash Flow
Capital Expenditures
(38)
(36)
(34)
(32)
(21)
(18)
(23)
(20)
(21)
(26)
Other Items
3
71
65
(223)
9
(193)
(394)
(685)
(661)
(990)
Cash from Investing Activities
(36)
N/A
36
N/A
31
-12%
(256)
N/A
(12)
+95%
(211)
-1 731%
(416)
-97%
(705)
-69%
(682)
+3%
(1 016)
-49%
Financing Cash Flow
Cash Paid for Dividends
0
0
0
0
0
0
(6)
(6)
0
0
Other
(10)
(56)
(56)
1 044
1 036
1 081
(20)
(13)
(19)
(23)
Cash from Financing Activities
(10)
N/A
(56)
-463%
(56)
-1%
1 044
N/A
1 036
-1%
1 081
+4%
(26)
N/A
(19)
+29%
(25)
-34%
(29)
-16%
Change in Cash
Effect of Foreign Exchange Rates
(1)
(2)
2
6
5
5
1
1
2
3
Net Change in Cash
68
N/A
91
+34%
104
+14%
947
+812%
1 160
+22%
1 018
-12%
(244)
N/A
(530)
-117%
(507)
+4%
(806)
-59%
Free Cash Flow
Free Cash Flow
76
N/A
77
+2%
93
+20%
121
+30%
110
-9%
126
+15%
175
+39%
173
-1%
177
+3%
210
+19%

See Also

Discover More